Lv1
80 积分 2022-04-06 加入
Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging
1年前
已关闭
Naturally Selected CD7 CAR-T Therapy without Genetic Manipulations for T-ALL/LBL: First-in-human Phase I Clinical Trial
2年前
已完结
Evaluation of cell surface markers and targets in leukemic stem cells (LSC) reveals distinct expression profiles, unique drug effects, and specific checkpoint regulation in AML LSC and CML LSC
3年前
已关闭
Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia
3年前
已关闭
皖公网安备34019202002308
